True Wealth Design’s TG Therapeutics TGTX Stock Holding History

True Wealth Design’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$660	Buy	+12	New	+$491	﹤0.01%	2110

Other funds holding TGTX

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

True Wealth Design's TGTX Position: Q2 2026 in Review

True Wealth Design opened a new position in TG Therapeutics (TGTX) in Q2 2026: 12 shares worth $660. The stake represents ﹤0.01% of the portfolio and ranks #2110 among its holdings.

65 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

True Wealth Design held 12 shares of TG Therapeutics worth $660 as of Q2 2026.
TG Therapeutics was a new True Wealth Design position in Q2 2026.
TG Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2110 holding.
65 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.